Predicting the probability of pT3 or higher pathological stage at radical prostatectomy: COVID19-specific considerations

BACKGROUND: We tested whether a model identifying prostate cancer (PCa) patients at risk of pT3-4/pN1 can be developed for use during COVID19 pandemic, in order to guarantee appropriate treatment to patients harboring advanced disease patients without compromising sustainability of care delivery. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Nocera, Luigi, Stolzenbach, Lara F., Collà Ruvolo, Claudia, Wenzel, Mike, Wurnschimmel, Christoph, Tian, Zhe, Gandaglia, Giorgio, Fossati, Nicola, Mirone, Vincenzo, Chun, Felix K. H., Shariat, Shahrokh F., Graefen, Markus, Saad, Fred, Montorsi, Francesco, Briganti, Alberto, Karakiewicz, Pierre I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763886/
https://www.ncbi.nlm.nih.gov/pubmed/36561531
http://dx.doi.org/10.3389/fonc.2022.990851

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763886/
https://www.ncbi.nlm.nih.gov/pubmed/36561531
http://dx.doi.org/10.3389/fonc.2022.990851

Ejemplares similares